Proteas eye top Test cricket spot in New Zealand South Africa open hostilities Friday against New Zealand on a six-week tour they hope will climax with a 3-0 Test sweep that would see them topple England from the top of the Test rankings.
DiagnoCure gets FDA nod for prostate cancer test, shares jump (Reuters) - Canada's DiagnoCure Inc said it received U.S. regulatory approval for a prostate cancer test that may help avoid unnecessary biopsies, sending its shares to their highest in about 18 months. "We expect it (the approval) will increase our royalty revenues," said Yves Fradet, chief medical officer of DiagnoCure, which was founded in 1994. Royalty revenue for the company, which has a ...
Cancer Breath Test Enters Clinical Trials A startup says its test can distinguish between subtypes of lung cancer. Someday soon a breath test could do more than just tell if you've been drinking. Metabolomx , a startup in Mountain View, California, recently completed a clinical trial that shows that its breath test can spot lung cancer with 83 percent accuracy and can also distinguish between several different types of the disease ...
Higher test scores show better college readiness, Grier says Higher test scores show better college readiness, Grier says Houston Chronicle Copyright 2012 Houston Chronicle. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Published 08:22Â p.m., Tuesday, February 14, 2012 Recent test scores show that the Houston Independent School District is doing a better job of preparing students for college ...
Attention Homeowners: Cub Cadet® Challenges You to Take a Test Drive CLEVELAND, Feb. 15, 2012 /PRNewswire/ -- Cub Cadet, the leader in premium quality outdoor power equipment, is challenging consumers to strap on their driving gloves and take the ultimate Cub Cadet Test ...
New Sequenom test could be prenatal game changer Three years after a data scandal led to a federal investigation and management shake-up, San Diego’s Sequenom has launched the new Down syndrome test at the center of the controversy.